NHLBI: Incorporating New Methodology in Asthma Clinical Trials
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level Two, Room 515B
2.50 CME/CE
Christine A. Sorkness , PharmD

Learning Objectives:
  1. Discuss how the age of the study population affects asthma clinical trials
  2. Discuss the process of data collection for biologic specimens and clinical data in asthma trials
  3. Discuss how data is converted into clinically meaningful information for patients with asthma
10:00 AM
Cross-Age Studies: Important Decisions
Stanley J. Szefler, MD FAAAAI
10:20 AM
Question & Answer
10:25 AM
Microbiome: Challenges and Opportunities
Susan V. Lynch, PhD
10:45 AM
Question & Answer
10:50 AM
Monitoring Asthma Control in Clinical Trials
David Mauger, PhD
11:10 AM
Question & Answer
11:15 AM
Composite Outcomes: Strengths and Weaknesses
Daniel J. Jackson, MD
11:35 AM
Question & Answer
11:40 AM
Case Study: Small Group Discussion
12:05 PM
Small Group Report-Out
12:20 PM
Panel Discussion Question & Answer
See more of: Session